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Abstract
The identification of predictive biomarkers is at the core of modern toxicology. So far, a number of approaches have been
proposed. These rely on statistical inference of toxicity response from either compound features (i.e., QSAR), in vitro cell
based assays or molecular profiling of target tissues (i.e., expression profiling). Although these approaches have already
shown the potential of predictive toxicology, we still do not have a systematic approach to model the interaction between
chemical features, molecular networks and toxicity outcome. Here, we describe a computational strategy designed to
address this important need. Its application to a model of renal tubular degeneration has revealed a link between physico-
chemical features and signalling components controlling cell communication pathways, which in turn are differentially
modulated in response to toxic chemicals. Overall, our findings are consistent with the existence of a general toxicity
mechanism operating in synergy with more specific single-target based mode of actions (MOAs) and provide a general
framework for the development of an integrative approach to predictive toxicology.
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Introduction
One of the mostchallenging tasks in toxicology is the identification
of a potential toxicity via high-throughput screening, avoiding the use
of animals, at an early stage in the development programme of a
product such as a pharmaceutical or in the context of REACH [1].
Such screens can help to reduce attrition of products late in
development and can help to prioritise existing chemicals for more
complete safety assessment. In this context, the concept of
quantitative structure activity relationship (QSAR) analysis was
originally developed with the purpose of predicting a toxicity or
pharmacological response utilizing information on the physico-
chemical features (PCFs) of a chemical and the relationship to
biological effects. In the last 20 years QSAR analysis has been
characterized by an increasing level of sophistication as technological
and computational developments have made it possible to measure
or compute a higher number of chemical and physical parameters
[2]. In addition, recent reports have shown that the prediction
accuracy of QSAR models can be increased when additional
information from cell based assays is utilized [3,4] Independently to
these developments, the availability of functional genomics technol-
ogies facilitated the measurement of mRNA concentrations, proteins
and metabolites in single experiments. This, together with the
developmentof novelcomputationalmethodssuitableforthe analysis
and integration of very large multilevel datasets [5], have contributed
to demonstrate the usefulness of molecular fingerprinting in
predicting toxicity from an early readout of the response to chemical
exposure [5–9]. Toxicants can in some cases be discriminated
according to their mechanism of action and their target organs
[10,11]. However, there have been no successful attempts to model
the interaction between a drug PCFs with genome wide molecular
response to exposure and put this in context with toxicity response. It
is therefore still unclear whether a true integration between
traditional QSAR and functional genomics data may be possible.
In this paper we describe an analysis strategy which addresses this
issue by integrating gene expression profiling measurements in the
logical framework of QSAR analysis. We have applied this approach
to a publicly available expression profiling dataset, representing the
pre-phenotypic transcriptional responseto chemical exposure ina rat
model of renal tubular degeneration which is a major toxicological
response contributing toattritionduring drug development [12].Our
approach has successfully linked a sub-set of PCFs to the activity of
signalling pathways known from the literature to drive effector
pathways differentially modulated between toxic and non-toxic
chemicals. This finding suggests the existence of general toxicity
mechanisms which operate in synergy with specific single-target
based MOAs. The approach we have used has general validity since
it can be applied to integrate different types of PCFs, molecular and
phenotypic measurements to identify predictors of toxicity within a
mechanistic framework for biological interpretation.
Results
Rational of the approach and data analysis overview
The dataset we have used in this analysis is based on a wide
range of chemicals. Some of them are known to work by different
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Despite this heterogeneity it has been shown that it is possible to
identify early molecular response signatures predictive of in vivo
toxicity outcome [13]. So far, it is unclear whether these signatures
represent an early convergence of the different drugs MOAs
towards common toxicity pathways or whether a component of
them may represent a direct interaction between the chemicals
and cellular components. Here we address this question by using a
multi-step computational approach. Firstly, we simplify the
complexity of the transcriptional response by computing indices
of overall pathway transcriptional activity (Figure 1, Step 1). This
effectively reduces the dataset from thousands of individual gene
expression profiles to 148 pathway indices. We demonstrate that
toxic and non-toxic chemicals can be separated on the basis of
their ability to modify pathway activity (Figure 1, Step 2 and 3).
This proves the biological relevance of the pathway indices. We
then hypothesize that the defined set of a drug PCFs may be
representative of the ability of a chemical to induce changes in the
homeostatic state of the target organ. In line with this hypothesis
we search for statistical models based on combinations of PCFs
and predictive of the transcriptional response to drug exposure
(Figure 2, Step 1). In parallel we identified which pathways are
differentially modulated between samples treated with toxic and
non-toxic drugs (Figure 2, Step 2). If these two pathway subsets
truly represent the interaction between chemicals and underlying
molecular networks we may expect that they would be part of a
super-pathway. This hypothesis was addressed by mapping
pathways in the two on the KEGG pathway map and testing for
statistical association (Figure 2, Step 3).
Computing indices of molecular pathway activity
The overall aim of this study was to link PCFs to drug-induced
molecular responses and phenotypic outcome. A key challenge in
identifying subsets of PCFs predictive of transcriptional response is
the astronomical number of possible combinations of PCFs and
gene subsets that need to be tested within a statistical modelling
framework. In order to address this challenge we first simplified
the complexity of the dataset by reducing thousands of individual
gene expression profiles to a relatively small number of overall
pathway activity indices. This was achieved by summarizing gene
expression profiles representative of a given KEGG pathway with
the first two principal components (PCs) of the gene expression
matrix [14]. The choice of the number of PCs to construct the
pathway activity indices was driven by the simple criteria to
represent at least 80% of the variance present in the original
dataset. By using this strategy we built a new dataset representing
148 KEGG Pathways (44% of the KEGG pathway database). This
dataset represents 1676 out of the 7478 genes which were
originally present in the processed Iconix dataset. We found that
the apparent loss of gene representation was largely (77%)
associated to the high frequency of non-annotated genes (i.e.
function unknown or estimated by sequence homology). KEGG
Pathways represented in the derived dataset are a good
representation of the spectrum of functions covered by the KEGG
database (Table S1 and S2 for a detailed breakdown in the
functional representation of the KEGG pathways represented in
the dataset).
Molecular pathway activity in response to chemical
exposure is correlated to toxicity
In their original paper, Fielden et al [13] demonstrated that
using statistical modelling techniques it is possible to identify
subsets of genes predictive of late toxicity outcome. Since our
strategy is based on simplifying the complexity of the data using
indices of pathway activity we first asked whether these were also
effective indicators of toxicity response. We first approached this
question by clustering the chemicals on the basis of their ability to
modify the transcriptional activity of a given pathway. Figure 3A
shows that the profile of pathway perturbation is indeed
informative of chemical toxicity. In particular, cluster analysis
succeeded in grouping 12 out of 15 nephrotoxic chemicals within a
well-defined cluster (Figure 3A). Analysis of the individual PCs
revealed that the second PC on its own was sufficient to reproduce
clustering of toxic chemicals without significant loss of information
(Figure 3B and 3C). In order to identify the molecular pathways
differentially modulated in response to toxic chemicals we directly
compared the index of pathway activity between samples treated
either with nephrotoxic or non-nephrotoxic chemicals. This
analysis identified 21 pathways which were differentially modu-
lated (FDRv1%, Table 1). These can be grouped into three main
functional categories: 1) metabolic pathways such as Glyceropho-
spholipid metabolism or Aminosugar metabolism, 2) pathways with a
strong signalling component such as Parkinson’s disease, Phosphatidy-
linositol signalling and Prostate cancer and 3) cell communication
pathways such as Cell communication and Focal adhesion. The KEGG
pathway terms Parkinson’s disease, Prostate cancer, Pancreatic cancer and
Renal cell carcinoma do not specifically include the term ‘signalling’
in their definition but are indeed representing primarily signalling
pathways. More specifically, the pathway Parkinson’s disease
represents the molecular events downstream dopamine stimula-
tion, which is a major player in synaptic transmission and it is
effectively linked to signalling pathways controlling vasoconstric-
tion. This pathway is important for kidney physiology where
dopamine release induce an increase in renal blood flow, urinary
volume and excretion of sodium and potassium. This then leads to
an increase in glomerular filtration rate as well as a depletion of
plasma cyclic AMP [15]. The pathway Prostate cancer represents
components of the MAPK signalling and p53 signalling pathways which
are included in the response downstream of cytokine stimulation.
Specific signalling pathways associated to the Pancreatic cancer
pathway are ErbB, Jak-STAT, VEGF, TGF-b, MAPK and the p53
signalling pathway. These are not only relevant to the biology of
cancer (alteration in these signalling pathways destabilize growth
inhibition and promote tumour growth activity [16]) but also to
kidney response to stress and regeneration [17].
Chemical features are predictive of molecular pathway
activity
Having demonstrated that indices of pathway activity are
representative of the biological effect of chemicals we addressed
the hypothesis that a subset of PCFs may be correlated to the
kidney transcriptional response to drug exposure. The statistical
framework we have used to address this hypothesis (described in
detail in the methods section) relies on a regression model
explaining the activity of a given pathway (which we remind is the
first or second principal component computed from the gene
expression matrix associated to a given pathway) as a linear
combination of three chemical features. The model also includes
interaction components to take into account potential synergistic
effects between chemical descriptors. We successfully identified
predictive models (R2w0:5) for 19 of the 148 pathways
represented in the Iconix dataset. It is worth noticing that,
pathway activity indices (Figure 3) as well as the original gene
expression data (Figure S1), separates toxic from non-toxic
chemicals across the second PC whereas the first component is
likely to represent non-specific effects (Figure S1). Therefore the
association between PCFs and the pathway activity indices build
using the second component is biologically reasonable. Among
Drug Features Link to Pathways
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number of signalling pathways as well as some metabolic pathways
(i.e. Glycolysis, Porphyrin metabolism, Chlorophyll metabolism and
Glutathione metabolism). Two of these pathways were also found to
be associated to toxicity in the analysis described in the previous
paragraph (Prostate cancer and Cell communication). PCFs selected in
the models could be assigned to several descriptor groups. Figure 4
summarizes in a graph format the most frequent combination of
features’ descriptors groups selected in the chemical feature
models. A key feature of the selected models is the importance
of interaction components which in most cases explain an average
of 50% of the model variance (Figure S2). Descriptor groups pairs
such as descriptors that describe patterns in the connection of
specific atoms with each other (ET-State) and Geometrical
descriptors or descriptors of special fragments that describe a
path or cycle (GSFRAG) with itself are predominantly chosen by
our method. All these descriptors classes capture different types of
structural information. For example, GSFRAG descriptors
identify specific chemical motives such as the size of a ring, or
the length of linear connections; ET-States descriptors describe
patterns in the connection of specific atoms with each other and
geometrical descriptors are designed to capture patterns in the
overall topology of the molecule.
Pathways whose activity is correlated to chemical
features are part of a signalling system closely connected
with cellular communication and related functions
Regression analysis described in the previous paragraph
identified 19 pathways whose activity could be predicted by a
combination of chemical features (See Figure 5 for some
examples). Because of the apparent similarity in the molecular
functions represented in these pathways we reasoned that these
may be closely connected within the KEGG pathway map. In
order to test this hypothesis we represented the relationship
Figure 2. Integrating pathways associated to PCFs and toxicity. Alongside using a regression based model to identify pathways associated to
PCFs (Step 1) we also identified pathways associated to toxicity by the use of the T2 statistics (Step 2). The resulting pathways were then mapped
onto a KEGG pathway map to identify clusters of pathways associated to both PCFs and toxicity (Step 3). Finally we asked the question if the PCFs we
have found to be associated to pathways are a better predictor of toxicity.
doi:10.1371/journal.pone.0012385.g002
Figure 1. Analysis strategy to compute indices of pathway activity. To compute the indices of pathway activity the first step is to summarize
the gene expression profiles using PCA according to KEGG pathways. This results in 148 pathway indices summarized using two PCs. These PC can
then be used as an input to a T2 Hotelling’s statistics to compute the perturbation index for a specific drug as compared to a matched control group.
The third step is to visualize the relationship between the drugs with the use of a hierarchical clustering. We can then show that the dimensionality
reduction in step 1 is biologically relevant to use in the subsequent analysis.
doi:10.1371/journal.pone.0012385.g001
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using hierarchical clustering. In this analysis KEGG pathways
which share a larger number of components are represented in
close proximity in the dendrogram. The visual inspection of the
dendrogram confirmed that pathways, whose overall activity can
be predicted by combinations of chemical features, were grouped
in a compact cluster within the KEGG map (Figure 6). This cluster
defines a KEGG super-pathway that represents a number of
signalling networks directly connected to effectors functions of
direct relevance with tissue morphogenesis such as Actin
remodelling and Cell communication. Interestingly, Cell communication
which we already mentioned to be associated to both PCFs and
toxicity represents multiple signalling and effectors components of
the cell to cell communication machinery. These include tight
Figure 3. Hierarchical clustering of chemicals based on pathway modulation profiles. The figure shows the clustering of chemicals on the
basis of the extent of change of transcriptional activity in molecular pathways after exposure. Panel A represent the relationship between the samples
when the change in pathway activity is represented simultaneously by the first and second PCs (multi-variate T2 Hotelling test). Panels B and C
represent respectively the results of cluster analysis when the change in pathway activity is estimated by the PC1 or the PC2 (univariate t-test). Notice
that toxic chemicals cluster (highlighted areas on Panels A and C) on the basis of the multivariate test and that the information associated to toxicity
is primarily represented by the PC2. Toxic chemicals have been highlighted using a red square on the left of each clustering.
doi:10.1371/journal.pone.0012385.g003
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extracellular matrix components. The cluster of interconnected
KEGG pathways defined by the association with chemical
physical features therefore represents a network of signalling
components which directly interact with a toxicity associated core
of cell communication components.
PCFs correlated to molecular pathway activity are best
predictors of chemical induced toxicity
The functional link between pathways associated to PCFs and
toxicity may imply that the selected PCFs may be themselves
predictive of renal tubular degeneration. In order to test this
hypothesis we developed multivariate statistical models predictive
of toxicity selecting from PCFs associated to molecular pathway
activity. We then compared these with models developed from
PCFs which where uncorrelated to the pathway associated PCFs
subsets. Figure 7A shows that features predictive of molecular
response are more predictive of toxicity outcome (average
accuracy of 76% versus 68%, p-value v10{3). In order to
identify the most representative PCFs subset, we developed
representative models based on the three features which were
most frequently represented in the model populations. Consistent
with the previous result, the model built using PCFs associated to
molecular response has higher sensitivity and specificity (sensitivity
0.781, specificity 0.871) than the one build with uncorrelated
PCFs. This is reflected by a clearer sample separation in the PCA
plot (Figure 7B). Features represented in the most predictive model
combine two RDF descriptors and a WHIM descriptor whereas
the unselected features model contains a GSFRAG, a GETAWAY
descriptor and a 2D-autocorrelation descriptor. The model based
on PCFs predictive of transcriptional response shows that toxic
chemicals are characterized by high polarisability (RDF020p), low
electronegativity (RDF040e) and low symmetry (G2u). Although
the difference in accuracy (8%) is not particularly high, the results
confirm that PCFs chosen by our method have a significantly
higher ability to discern toxic from non-toxic chemicals.
Discussion
The most important finding of our study is the demonstration
that specific combinations of chemical descriptors can be
predictive of the transcriptional activity of pathways, always using
the second PC, representing the molecular state of a target organ
after chemical exposure. These pathways (i.e. ErbB Signalling, Wnt
signalling, Long-Term Depression, Long-Term Potentiation and several
cancer pathways) mainly represent signalling pathways which in
our model define the main domain of interaction between
chemicals and cellular molecular response (Figure 8). We have
shown that toxicity pathways with relevance to renal tubular
degeneration are closely associated to this domain in the context of
a KEGG pathway map. We explored close pathways by
integrating the networks and establish whether, beyond the
topological proximity, we could also identify a functional
relationship between them. In this context we devised three
interconnected pathways that could mechanistically explain the
observed connection between chemical features, pathway activity
and toxicity outcome. Figure 8A shows how a possible interaction
between the Wnt signalling pathway, Regulation of Actin Cytoskeleton
(linked to PCFs) and Focal Adhesion (predictive of toxicity outcome)
could lead to a perturbation of actin cytoskeleton polymerization.
More specifically, Wnt/Fz signalling activates the small GTPase
Rho to control cell migration during tissue remodelling and
development. This activation requires Dvl-Rho complex forma-
tion which is assisted by Daam1. From this it is clear that the
integration of these topologically linked pathways represent a true
series of biochemical events linking the binding of the Wnt ligand,
through activation of Daam1 to the actin polymerization
machinery. A plausible disturbance of mitochondrial respiration
and energy balance by means of reactive oxygen species (ROS)
generation is shown in Figure 8B. Lastly growth factor mediated
modulation of the cell cycle, adhesion and cell migration through
TGF-a is shown in Figure 8C. This pathway module results from
the integration of the ErbB signalling pathway (linked to PCFs) and
Pancreatic Cancer (predictive of toxicity outcome). In this case the
pathway linked to toxicity is a sub-network of the ErbB signalling
pathway which represents the specific effects on tissue remodelling
via regulation of cell growth, apoptosis and differentiation. The
common feature among these hypothetical mechanisms is the
association between chemical features and membrane associated
cellular signalling and the large overlap between this and effectors
pathways. Genes within each pathway are co-ordinately regulated
across exposures suggesting that what we are modelling is not the
effect of a small subset of highly regulated genes. Moreover, by
mapping the direction of change between toxic and non-toxic
chemicals on the KEGG pathway maps we observe that chemical
exposure is associated to a coordinate overexpression of genes in
signalling and effector genes (Figures S3, S4, S5, S6, S7, S8, S9,
S10, S11, S12, S13, S14, S15, S16). It is therefore not
unreasonable to hypothesize that the diverse spectrum of toxic
chemicals used in this study may act via a general mechanism
involving interaction with cellular membranes. This hypothesis is
also consistent with the finding that polarisability is a key feature of
Table 1. This table shows 21 KEGG pathways that were found
to be significantly perturbed by nephrotoxic chemicals
(FDRv1%).
KEGG ID Pathway Name Size T2 Score
rno05020 Parkinson’s disease 10 31.71
rno00564 Glycerophospholipid metabolism 25 31.29
rno05215 Prostate cancer 52 26.66
rno02010 ABC transporters - General 13 26.35
rno04070 Phosphatidylinositol signaling system 32 22.56
rno04130 SNARE interactions in vesicular transport 24 21.54
rno00760 Nicotinate and nicotinamide metabolism 10 21.17
rno01430 Cell Communication 45 21.07
rno00530 Aminosugars metabolism 9 20.77
rno04120 Ubiquitin mediated proteolysis 65 20.40
rno05030 Amyotrophic lateral sclerosis (ALS) 16 19.64
rno03010 Ribosome 26 19.54
rno03050 Proteasome 20 19.35
rno05212 Pancreatic cancer 50 19.21
rno00230 Purine metabolism 64 16.14
rno04330 Notch signaling pathway 20 15.31
rno01031 Glycan structures - biosynthesis 2 17 14.96
rno04612 Antigen processing and presentation 23 14.96
rno04510 Focal adhesion 102 14.49
rno04320 Dorso-ventral axis formation 17 14.32
rno05211 Renal cell carcinoma 52 13.71
The number of genes in each pathway and the value of the T2 hotelling
statistics are shown respectively in the third and fourth columns size column.
doi:10.1371/journal.pone.0012385.t001
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between chemicals and cellular membranes may perturb receptor
signalling inducing changes in the expression of genes encoding for
signalling components and ultimately creating an unbalance in the
expression of effectors pathways involved in tissue dynamics and
homeostasis. The regression models we built showed that, in many
cases, there is a continuum of effects influencing the molecular
state of a target pathway and that, in specific pathways, (i.e. Gap
junction and ErbB signalling pathways) toxicity is observed either
above or below a given threshold of pathway activity (Figure 5).
This is showing that only chemicals that can substantially perturb
key signalling pathways are able to induce stress responses such as
disturbance of inter-cellular communication and mitochondrial
disturbances that are frequently associated with subsequent
cellular toxicity [18,19]. It is possible that the proposed mechanism
may be a general unifying mode of toxicity probably secondary to
a range of initial specific mechanisms and that may act in parallel
to the interaction with specific molecular targets. In this context, it
is known that multiple and target-specific mechanisms of action of
xenobiotics are responsible for drug induced nephropathy. For
example, the targets of the initial insult may be at the level of
altered blood flow, glomerular injury, direct proximal tubule
damage or other tubule or papillary targets [20]. Furthermore
nephropathy might be a direct action of the agent on nephrons or
an indirect action such as via a reduction of prostaglandin
production such as with salicylic acid, or via precipitation of liver-
derived alpha-2-u-globulin as a result of chemical binding (e.g. d-
limonene) [21]. Prominent as classes of nephrotoxic agents are
halogenated hydrocarbons such as chloroform and bromobenzene
and classes of therapeutic agents including nonsteroidal anti-
inflammatory drugs, aminoglycosides and the anticancer agent
cisplatin. These facts might suggest insurmountable difficulties in
prediction of effects from structural characteristics because of a
multiplicity of mechanisms. However, the focus of this paper is
predominantly on agents that directly act on the tubular
(principally proximal tubule) epithelial cells. Our study has shown
that there are features of signalling disturbance that associate with
both chemical structural parameters and also with additional
molecular pathways that associate with toxicity. Integration of the
datasets shows that it is possible to link structure to pathology via
the two layers of analysis allowing a reconstruction of a series of
pathways. The approach offers a new dimension to the existing
strategies of databases that associate structure directly to known
toxicity features through training (e.g. DEREK and TOPKAT
[22] and the OECD Toolbox (www.oecd.org). The common
signalling disturbance identified is thus hypothesised to lead to
secondary effects linked to toxicity. It is the genome-wide
surveillance strategy that has allowed the identification of the
linkage which would not have been possible from more targeted
analysis of individual mechanisms. Since the time point for the
molecular changes observed is five days after exposure, it is also
possible that the changes represent secondary intermediate modes
of change rather than specific early mechanistic interactions.
Interestingly, the modelled features associated with toxicity are not
necessarily limited to nephrotoxicity. The biological implications
of this work are further strengthened by the observation that
chemical feature selection based on functional pathway activity
leads to more predictive toxicity models (sensitivity 78.1%,
specificity 87.1%). Therefore linking gene expression to chemical
features identifies a sub-selection of features which are more linked
to toxicity. We therefore propose that by integrating gene
expression profiles with chemical feature information it may be
possible to isolate a sub-group of features that are highly important
in characterizing specific phenotypic effects allowing for a much
better characterization of yet untested chemicals. The develop-
ment of these methodologies is particularly important as large
Figure 4. Visual summary of descriptor connections. The network represents the number of interactions between PCFs descriptor groups
computed from pooled models. The thickness of the line is proportional to the number of pathways in which PCFs of a given descriptor group are
selected in an interaction component of a predictive models. The highest value edge is found between ET-State and Geometrical descriptors in which
11 out of 19 pathways were found to contain models based on features from these 2 descriptor groups.
doi:10.1371/journal.pone.0012385.g004
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expected to become available. An excellent example of these
publicly available datasets is the ToxCast
TM [23] program which
is currently running at the U. S. Environmental Protection Agency
[24]. Several potential improvements may be necessary to make
the approach fully generalizable. For example, the computation of
pathway indices we have implemented is based on the use of PCs
ensuring that a large percentage of variance (80% in this case) is
retained. Although this is likely to work for most of the datasets, it
is possible that PCA, which is based on a linear combination of
variables, may not be able to capture more complex relationships
with PCFs. Therefore it may be useful to consider other methods
such as independent component analysis or a non-linear version of
PCA. This issue is particularly important considering that in
Figure 5. Example models linking PCFs with molecular pathway activity. The figure shows the relationships between the observed (x axis)
and predicted (y axis) indices of pathway activity for a number of exemplar KEGG pathways. Nephrotoxic samples are represented by red dots
whereas non-nephrotoxic samples are represented by black dots. Gap Junction and ErbB Signaling Pathway contain features belonging to ET-State
indices, Geometrical descriptors and RDF descriptors. The R2 values are 0.55 and 0.57 respectively. Wnt Signaling Pathway and Adipocyte Signaling
Pathway contain features belonging to GSFRAG, Information indices, Edge adjacency indices and 3D-MoRSE descriptors. The R2 values are 0.52 and
0.51 respectively. Note that models containing a feature from E-State indices and RDF descriptors better separate nephrotoxic and non-nephrotoxic
samples.
doi:10.1371/journal.pone.0012385.g005
Drug Features Link to Pathways
PLoS ONE | www.plosone.org 8 August 2010 | Volume 5 | Issue 8 | e12385Figure 6. KEGG Pathway topology map. The Figure shows a dendrogram representing the degree of similarity between different KEGG
pathways. Pathways marked in red are pathways that were found to be associated to chemical features (19), and pathways marked in blue have been
found to be predictive of toxicity (21). Pathways whose activity is predicted by PCFs group in a tight cluster. Note that the majority of toxicity
annotated pathways cluster towards the lower half of the dendrogram, close to pathways linked to PCFs.
doi:10.1371/journal.pone.0012385.g006
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associated to the interesting biological effect may be associated
to non-specific effects of toxicity. It is therefore important that the
procedure used for the construction of pathway indices has the
potential to decompose these effects. However, even at the present
stage of development, the broad application of the analysis strategy
we have pioneered will improve our ability to identify mechanistic
markers of toxicity and will help to better understanding the
relationship between drug PCFs and cellular physiology.
Methods
The Dataset
The expression profiling dataset used in this analysis was
originally developed by Iconix Biosciences [13]. It is at present the
largest microarray-based analysis of chemical induced transcrip-
tional response on a mammalian system being available in a public
domain. In this study, rat kidneys have been profiled five days after
exposure in a 28-day repeat-dose study in male Sprague-Dawley
rats. The study involved 88 chemicals, 22 of which are known to
induce renal tubular degeneration at the concentrations used in
this study. Details of the experimental protocol are available in the
original publication. Here we report a summary for clarity of the
manuscript. Rats were treated daily and sacrificed on days 5 (n=5
rats) and 28 (n=10 rats) for kidney histopathology evaluation.
Gene expression profiles were obtained on day 5 from 3 randomly
chosen rats per treatment group, before the expected appearance
of the lesions. Doses were chosen so as to not cause histological or
clinical evidence of renal tubular degeneration after 5 days of
dosing, but to cause late-onset histological evidence of tubular
degeneration as expected from the literature. The negative class of
this dataset was defined based on literature knowledge of
Figure 7. PCFs linked to molecular response are better predictors of toxicity. Panel A shows the comparison between the classification
accuracy of models predictive of toxicity and developed selecting from PCFs which are predictive of molecular response and those developed using
uncorrelated PCFs. Note that PCFs linked to molecular response have a higher predictivity (pv10{3). Panels B and C show the PCA representation of
the samples using the 3 most represented features in the model populations. The information for the best separation in both instances is present in
PC2 and PC3. The equations for panel B show that a high increase in symmetry and high polarizability and low electronegativity is predictive of
toxicity. In the case of the unselected features panel C toxic chemicals do cluster together but are specific to containing a nitrogen with a triple single
bond and a low autocorrelation.
doi:10.1371/journal.pone.0012385.g007
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PLoS ONE | www.plosone.org 10 August 2010 | Volume 5 | Issue 8 | e12385Figure 8. Association between PCFs and toxicity associated pathways. The figure represents the detailed relationship between pathways
associated to chemical hits and pathways associated to toxicity. Pathways with membrane component were mostly associated to chemical hits
whereas pathways with downstream signalling components were mostly associated to toxicity. This figure represents three possible links between
Drug Features Link to Pathways
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non-nephrotoxic compound treatments that were administered
daily for 5 or 7 days (n=3 rats). The dose was an empirically
determined maximum tolerated dose in order to ensure sufficient
exposure, but not to cause overt clinical toxicity. This was defined
as the dose that causes approximately a 50% decrease in body
weight gain relative to controls during the course of the 5-day
range finding study, and without severe clinical signs of toxicity.
Summarizing the transcriptional state of kidney using
indices of pathway transcriptional activity
In order to reduce the complexity of linking chemical
descriptors to the kidney transcriptional state we have computed
indices of overall pathway transcriptional activity [25,26]. These
indices were computed by mapping the 7478 genes represented in
the pre-processed dataset [13] onto KEGG pathways. In choosing
the number of PCs we have used the simple criteria of selecting
subsequent components to explain at least 80% of the variance. In
this dataset this lead to the selection of the first two components.
Using this criteria we summarized the activity of pathways
including more than 5 genes (148) by computing the first two
principal components (PCs) which were always able to summarize
up to 89% of the variance. The advantage of using PCs is that the
inter-gene correlation structure is automatically incorporated into
the process of dimension reduction, so this information is not lost.
Computation of the PCs has been performed using the principal
component function prcomp within the software programming
environment R [27].
Comparing indices of pathway activity in response to
chemical exposure
In this analysis we have compared indices of pathway activity
between treated samples and matched controls (Figure 1, Step 2)
and between toxic and non-toxic chemicals (Figure 2, Step 2). In
both cases significantly differentially modulated pathways have
been identified by a combination of dimension reduction via
Principal Coordinates with Hotelling’s multivariate extension of
the t-test. Versions of this approach were independently developed
by Kong et al. [28] and Song et al. [29], and made available in the
R Bioconductor package pcot2 [29]. As mentioned in the previous
paragraph, one of the advantages of using PCs is the fact that the
inter-gene correlation structure is incorporated into the process of
dimension reduction. The Hotelling’s T2 procedure, applied to
both pathway components allows this correlation to be included in
the test statistic for each pathway modules [30]. In the first case the
output of the T2 Hotelling’s test has been used as an index of drug
effectiveness to perturb the homeostatic state (Figure 1, Step 2).
Indices have then been used as inputs in a hierarchical clustering
procedure to compare drugs perturbation profiles. In order to
identify which PC most contributes to the separation a univariate
t-test has been applied to the first and second PC separately and
the resulting dendrograms compared (Figure 3). In the second case
the T2 Hotelling’s test has been used to identify pathways that are
differentially modulated between toxic and non-toxic chemicals
(Figure 2, Step 2). The p-values obtained from this test were
corrected for multiple testing using the Benjamini and Hochberg
method [31]. Pathways with an FDRv1% were considered
differentially active between the two experimental groups.
Deriving chemical physical features (PCFs)
PCFs were computed using the Web-based toolset e-dragon
[32]. E-dragon computes 2352 chemical descriptors by integrating
several publicly available methodologies. Only features that could
be computed for all chemicals in the dataset were used leading to a
total of 1515 chemical physical descriptors (Dataset S1).
Linking chemical features to pathway activity
components
In order to link chemical descriptors to a given pathway
component we used a regression model based on the combination
of three chemical descriptors, including interaction components
(Equation 1). More precisely, we define:
PCi,k~ah1zbh2zch3zdh1h2zeh1h3zfh2h3zgzE ð1Þ
Where PCi,k is the principal component i of pathway k. h1, h2 and
h3 are three different given chemical descriptors, a, b, c, d, e, f, g
are model parameters and E is the noise model component. In
order to select an optimal subset of chemical descriptors we have
used a genetic algorithm (GA) based methodology as implemented
in the R package GALGO [33]. We used this random search
procedure to find an optimal sub-set of variables to maximize the
model R2 value. In this application, data where split in training (2/
3 of the samples) and test (1/3 of the samples) sets. The training set
was used as an input to the GA procedure to search for predictive
models. The fitness function was implemented as a linear model
denoted in (1). The fitness value for model selection was set to
R2w0:5. To estimate the R2 accurately a 5-fold cross validation
procedure was used. The GA procedure was then allowed to run
for 1000 simulations. Pathways for which we could identify
predictive models were considered for further analysis. This
resulted in the identification of 19 pathways linked to PCFs
(Table 2, Table S3 for further details). Figure 5 shows examples of
models found by the GA in which the predicted values using an
optimized model are plotted against the observed PC values for a
given pathway.
Creating and visualizing a KEGG pathway map
In order to visually represent the relationship between the
different KEGG pathways we computed a pathway similarity
matrix based on the Jaccards Index of overlap. This is defined as
the ratio between the numbers of genes shared by any two
pathways (intersection) divided by the number of unique genes in
the two combined pathways (union). The resulting matrix was
used as an input to a hierarchical clustering procedure (average
linkage). The effectiveness of the clustering procedure in
representing the information described by the similarity matrix
has been verified using the cophenetic function correlation fit to
the input overlap matrix (r=0.9).
Predicting renal tubular degeneration from chemical
descriptors
Different subsets of chemical features were used to develop
multivariate predictors of chemical toxicity using a classis QSAR
methodology. The first subset (92 features) was defined including
descriptors represented in the models predictive of pathway
activity whereas the second subset included all variables not
pathways associated to chemical hits (Wnt Signaling Pathway, Long-Term Depression and ErbB Signaling Pathway) and toxicity (Focal Adhesion, ALS and
Pancreatic Cancer) through shared genes between the pathways. Although each link presents a mechanism of action these were only implied by the
pathway associated to toxicity. Genes found to be up or down regulated have been marked with a red or a blue arrow respectively.
doi:10.1371/journal.pone.0012385.g008
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absolute pearson coefficient of less than 0.5, to PCFs from the first
group (210 features). Models were developed using a maximal
likelihood discriminant function coupled to a genetic algorithm for
variable selection using default settings [33]. A forward selection
approach was used to identify the single smallest model, with the
least number of descriptors and with the highest classification
accuracy [33]. Classification accuracy was estimated using a k-
folds cross-validation procedure. Interpretation of the models has
been performed with the help of PCA.
Supporting Information
Figure S1 PC1 and PC2 relationship to toxicity. A) PCA
scatterplot of the chemical space using all genes clustered into
KEGG Pathways. Chemicals marked black or red are nephrotoxic
and non-nephrotoxic respectively. B) Boxplot showing the
separation on the second component between nephrotoxic and
non-nephrotoxic chemicals. A t-test between the two sets has a p-
value ,0.001. C) Dose separation on the PCA plot. Low-dose
chemicals are marked in red, and high-dose chemicals in black.
We observe a diagonal relationship between PC1 and PC2
separating the dose. More specifically, as shown in (a) the toxic
chemicals separate on the 2nd PC. This implies that part of the
non-toxic dose component is summarized in PC1.
Found at: doi:10.1371/journal.pone.0012385.s001 (0.38 MB TIF)
Figure S2 Distribution of interaction components. The figure
shows the distribution of interaction components for the 19
pathways found to be associated to chemical features. It can be
seen that most of the interaction components add more than 50%
towards the resulting model.
Found at: doi:10.1371/journal.pone.0012385.s002 (0.03 MB TIF)
Figure S3 Heatmap of the genes belonging to Amyotrophic
lateral sclerosis (ALS).
Found at: doi:10.1371/journal.pone.0012385.s003 (2.19 MB TIF)
Figure S4 PC2 loadings of the genes belonging to the
Amyotrophic lateral sclerosis (ALS).
Found at: doi:10.1371/journal.pone.0012385.s004 (0.01 MB TIF)
Figure S5 Heatmap of the genes belonging to regulation of actin
cytoskeleton.
Found at: doi:10.1371/journal.pone.0012385.s005 (3.06 MB TIF)
Figure S6 PC2 loadings of the genes belonging to regulation of
actin cytoskeleton.
Found at: doi:10.1371/journal.pone.0012385.s006 (0.02 MB TIF)
Figure S7 Heatmap of the genes belonging to ErbB signaling
pathway.
Found at: doi:10.1371/journal.pone.0012385.s007 (3.51 MB TIF)
Figure S8 PC2 loadings of the genes belonging to ErbB
signaling pathway.
Found at: doi:10.1371/journal.pone.0012385.s008 (0.01 MB TIF)
Figure S9 Heatmap of the genes belonging to focal adhesion.
Found at: doi:10.1371/journal.pone.0012385.s009 (4.23 MB TIF)
Figure S10 PC2 loadings of the genes belonging to focal
adhesion.
Table 2. This table lists the 19 pathways whose activity could be predicted by combinations of PCFs.
KEGG ID Pathway R
2 average R
2 Feature Type
rno04810 Regulation of actin
cytoskeleton
0.53 0.53 GETAWAY descriptors GETAWAY descriptors ET-state Indices
rno05222 Small cell lung cancer 0.52 0.57 RDF descriptors GSFRAG Descriptor GETAWAY descriptors
rno04310 Wnt signaling pathway 0.53 0.57 GSFRAG Descriptor Information indices GSFRAG Descriptor
rno04540 Gap junction 0.53 0.57 Geometrical descriptors ET-state Indices 3D-MoRSE descriptors
rno04720 Long-term potentiation 0.53 0.57 GETAWAY descriptors Information indices GSFRAG Descriptor
rno04730 Long-term depression 0.53 0.54 RDF descriptors ET-state Indices Geometrical descriptors
rno04912 GnRH signaling pathway 0.52 0.55 GETAWAY descriptors WHIM descriptors WHIM descriptors
rno04916 Melanogenesis 0.52 0.53 3D-MoRSE descriptors Geometrical descriptors ET-state Indices
rno00860 Porphyrin and chlorophyll
metabolism
0.52 0.53 ET-state Indices GSFRAG Descriptor WHIM descriptors
rno00010 Glycolysis/Gluconeogenesis 0.52 0.53 GSFRAG Descriptor GSFRAG Descriptor WHIM descriptors
rno01430 Cell Communication 0.52 0.57 Geometrical descriptors ET-state Indices GETAWAY descriptors
rno04920 Adipocytokine signaling
pathway
0.51 0.53 GSFRAG Descriptor GSFRAG Descriptor 2D autocorrelations
rno04012 ErbB signaling pathway 0.53 0.57 RDF descriptors ET-state Indices Geometrical descriptors
rno05215 Prostate cancer 0.52 0.53 RDF descriptors GSFRAG Descriptor GETAWAY descriptors
rno04664 Fc epsilon RI signaling pathway0.53 0.55 3D-MoRSE descriptors GSFRAG Descriptor 2D autocorrelations
rno05214 Glioma 0.52 0.55 3D-MoRSE descriptors Molecular properties Topological charge
indices
rno05218 Melanoma 0.51 0.59 ET-state Indices 3D-MoRSE descriptors Geometrical descriptors
rno04930 Type II diabetes mellitus 0.53 0.57 WHIM descriptors GSFRAG Descriptor GSFRAG Descriptor
rno00480 Glutathione metabolism 0.51 0.54 Edge adjacency indices Information indices 3D-MoRSE descriptors
For each pathway the average R2 value given the model population, the model with the highest R2 value and the descriptor group features responsible for the
correlation are shown. A detailed table with the features that have been selected for these models can be found in Table S3.
doi:10.1371/journal.pone.0012385.t002
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Figure S11 Heatmap of the genes belonging to long-term
depression.
Found at: doi:10.1371/journal.pone.0012385.s011 (2.38 MB TIF)
Figure S12 PC2 loadings of the genes belonging to long-term
depression.
Found at: doi:10.1371/journal.pone.0012385.s012 (0.01 MB TIF)
Figure S13 Heatmap of the genes belonging to pancreatic
cancer.
Found at: doi:10.1371/journal.pone.0012385.s013 (3.77 MB TIF)
Figure S14 PC2 loadings of the genes belonging to pancreatic
cancer.
Found at: doi:10.1371/journal.pone.0012385.s014 (0.01 MB TIF)
Figure S15 Heatmap of the genes belonging to Wnt signaling
pathway.
Found at: doi:10.1371/journal.pone.0012385.s015 (3.63 MB TIF)
Figure S16 PC2 loadings of the genes belonging to Wnt
signaling pathway.
Found at: doi:10.1371/journal.pone.0012385.s016 (0.02 MB TIF)
Table S1 Representation of KEGG pathways. This table shows
the KEGG pathways represented in this dataset and their relative
sizes.
Found at: doi:10.1371/journal.pone.0012385.s017 (0.05 MB
XLS)
Table S2 KEGG pathway occurency table. This table shows the
percentage of KEGG pathways found in each high level pathway
category in the KEGG Pathway Database.
Found at: doi:10.1371/journal.pone.0012385.s018 (0.02 MB
XLS)
Table S3 Detailed model description. Here, we show a detailed
description of a model for each pathway with the highest R
2 value.
Found at: doi:10.1371/journal.pone.0012385.s019 (0.04 MB
XLS)
Dataset S1 Supplementary dataset.
Found at: doi:10.1371/journal.pone.0012385.s020 (2.01 MB
CSV)
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